Obsessive Compulsive Disorder: Pharmacologic Approaches

[1]  T. Insel,et al.  Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. , 1983, Archives of general psychiatry.

[2]  T. Insel,et al.  Growth Hormone Response to Clonidine in Obsessive-Compulsive Patients , 1983, British Journal of Psychiatry.

[3]  T. Insel,et al.  The sleep of patients with obsessive-compulsive disorder. , 1982, Archives of general psychiatry.

[4]  T. Insel,et al.  The dexamethasone suppression test in patients with primary obsessive-compulsive disorder , 1982, Psychiatry Research.

[5]  M. Åsberg,et al.  Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. , 1980, Archives of general psychiatry.

[6]  I. Marks,et al.  Clomipramine and Exposure for Obsessive-Compulsive Rituals: 1 , 1980, British Journal of Psychiatry.

[7]  S. B. Ross,et al.  Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues , 1977, Neuropharmacology.

[8]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.

[9]  J. Ananth,et al.  Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. , 1981, Progress in neuro-psychopharmacology.

[10]  D. Luscombe,et al.  Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis. , 1980, Postgraduate medical journal.

[11]  Luscombe Dk,et al.  Some pharmacological aspects of desmethylclomipramine. , 1980 .